Anavex Life Sciences Corp (AVXL)

[nidan7500]

RedShoulder

Quote:
Within a five-year span, the plan will focus on bolstering scientific advancement and promoting innovation for rare neurodegenerative diseases by engaging in targeted activities including:

Establishing the FDA Rare Neurodegenerative Diseases Task Force (FY 22).
Establishing the public-private partnership for rare neurodegenerative diseases (FY 22).
Developing disease-specific science strategies (FY 22 – FY 26).
Leveraging ongoing FDA regulatory science efforts.


Nice find abew; this FDA plan plays right into Anavex's strength of their portfolio of rare neurodegenerative diseases.

Agree, it is nice to see the FDA finally recognize reality, even though it seems they are being dragged kicking and screaming into something they can actually be MEASURED AGAINST PLANNED PERFFORMANCE. Let's see how they do with reality.